LVIS Corporation
LVIS revolutionizes neurological disease treatment with AI-powered brain network analysis tools, enhancing diagnosis accuracy and reducing treatment costs.
LVIS Corporation specializes in developing brain network analysis tools designed to decode brain networks and find cures for neurological diseases. Their products include:
- NeuroMatch: An AI-powered software for EEG analysis that uses 4D visualization to assist in diagnosing and treating epilepsy.
- NeuroMatch Cloud: A cloud-based platform for EEG data storage, allowing for remote collaboration and access among clinicians.
Vision and Mission: LVIS aims to revolutionize the study and treatment of neurological diseases through advanced brain network analysis. Their mission is to provide innovative tools that enable physicians to understand the causes of neurological disorders and develop effective treatments, ultimately improving patient outcomes.
Noteworthy Points:
- LVIS’s digital-based software significantly reduces treatment time and cost.
- The company leverages AI and live visualization to enhance the accuracy of neurological diagnoses.
- LVIS has raised $15.5 million in funding and is backed by investors including LG Electronics and SK Networks.